The DOJ's complaint alleges that the deal would remove competition between UHG and Amedisys due to UHG's previous acquisition of home health and hospice company LHC Group.
Experts are unsure what the outcome of this lawsuit will be particularly under the incoming Trump administration, which may have a different M&A policy than the Biden administration.
The main reason for antitrust lawsuits - prices would rise as a result of the transaction, hurting consumers and patients - seems to be missing from the equation here.
According to the DOJ's complaint, "competition between UnitedHealth and Amedisys benefits millions of Americans who need home health or hospice services."
Collection
[
|
...
]